FLT3 and acute myeloid leukemia: Targeted sequencing of single cells derived from patients with R/R AML showed polyclonal blast populations harboring several subclones with compound mutations (ITD plus distinct D835 mutations—D835V, Y or F) as well as FLT3-ITD negative subclones with newly acquired FLT3-TKD mutations.